Dr. Danny Winder's research lab focuses on understanding how alcohol affects sleep and the brain's arousal pathways, especially in individuals with alcohol use disorders. Their work aims to uncover the complex mechanisms linking alcohol consumption with sleep disturbances, using advanced techniques to analyze how specific brain pathways are influenced by alcohol. This research is important for developing better treatments for sleep issues related to alcohol dependence.

Dr. Ying Leong Chan's lab at the University of Massachusetts focuses on understanding how exposure to heavy metals, like cadmium, influences Alzheimer's disease. They use innovative human-derived brain models to explore how genetic factors and viral infections, specifically the herpes simplex virus, might interact to accelerate Alzheimer's-related changes in the brain. The work aims to uncover new insights into the disease's causes and develop potential treatment approaches.

Dr. A. M. Barrett's lab focuses on understanding how medication self-administration (MSA) can indicate early signs of cognitive impairment, including Alzheimer's Disease. By studying individuals in the Framingham Heart Study, the lab aims to link errors in medication management and self-assessment of these abilities to cognitive decline and brain health. Their research has significant implications for improving caregiving practices and adjusting healthcare approaches for the aging population.

Dr. Jeanne Bentley Lawrence's lab studies how an extra copy of chromosome 21 impacts cellular processes related to Down Syndrome and early-onset Alzheimer's disease. They focus on understanding the roles of non-coding RNAs and how they contribute to cell development and brain function. The lab employs innovative methods to investigate the molecular underpinnings of these conditions, aiming to inform therapeutic strategies that may be able to correct cognitive deficits associated with Down Syndrome.

Dr. Andrew R. Tapper's lab focuses on understanding how stress affects motivation for reward-seeking behaviors, particularly through the brain's dopaminergic pathways. By exploring specific neuronal circuits in the interpeduncular nucleus, the research aims to uncover how stress can influence reward-related behaviors, which may provide insights into the underlying mechanisms of neuropsychiatric disorders. The lab employs cutting-edge techniques to study these complex interactions in animal models, contributing to the development of potential new treatments.

Dr. Patrick Emery's lab studies how circadian rhythms and sleep are regulated at a molecular level using fruit flies (Drosophila melanogaster). The lab focuses on understanding the genetic and cellular mechanisms that control these biological rhythms, especially how they adapt to changes in the environment. Insights from this research could have significant implications for human health, particularly regarding diseases linked to disrupted sleep patterns.

Dr. Fen-Biao Gao's lab focuses on understanding frontotemporal dementia (FTD), a serious condition that affects behavior and language primarily in younger individuals. They explore the disease using advanced models like fruit flies and neurons derived from stem cells to uncover the genetic and molecular basis of FTD. The ultimate goal is to identify new targets for therapy and to help in the search for effective treatments for this challenging neurodegenerative disorder.

Dr. Alexandra Byrne's lab at the University of Massachusetts Medical School focuses on understanding how gut bacteria influence brain health and could protect against diseases like Alzheimer's. Using a simple worm model, they investigate how specific bacteria and their products can prevent nerve cell degeneration. This research aims to link the microbiome with neuroprotection, potentially leading to new strategies for treating neurodegenerative diseases.

Dr. Kensuke Futai's lab at the University of Massachusetts Medical School focuses on understanding how serotonin signaling differs between males and females, particularly in the context of autism spectrum disorder (ASD). The lab studies the molecular mechanisms involving Neurexins, which are proteins that play a vital role in the formation and regulation of synapses in the brain. Through their research, the lab aims to uncover how these mechanisms contribute to the gender bias observed in ASD diagnoses and could help identify new treatment targets for cognitive and behavioral deficits associated with neurodevelopmental disorders.